BioCentury

8:00 AM GMT, Jan 12, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Finance

New products to watch

New products to watch

Selected drugs that received regulatory approval in 2008.

Company Product Indication 2008 approval
Abbott (NYSE:ABT) Simcor extended-release niacin / immediate-release simvastatin Manage cholesterol in patients with complex lipid disease when treatment with either therapy alone is not adequate U.S.
Adolor (NASDAQ:ADLR)/ GlaxoSmithKline (LSE:GSK; NYSE:GSK) Entereg alvimopan Postoperative ileus (POI) U.S.
Alcon (NYSE:ACL) Patanase olopatadine hydrochloride nasal spray Seasonal allergic rhinitis U.S.
Allergan (NYSE:AGN) Trivaris triamcinolone Intravitreal, intramuscular or intra-articular injection to treat sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids U.S.
Allergan (NYSE:AGN) Latisse bimatoprost ophthalmic solution 0.03% Hypotrichosis

Read the full 1190 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.